10X Genomics

Historical price data

10X Genomics is a pioneer in single-cell and spatial biology, providing powerful, reliable tools that fuel scientific discoveries and drive exponential progress in understanding biology to advance human health. The company's technology platforms—Chromium for single-cell multiomics, Xenium for high-resolution spatial imaging, and Visium for spatial discovery—are backed by over $1.5B in R&D investment and cited in more than 10,000 publications. Its products are used across diverse fields including cancer research, immunology, neuroscience, and drug development, empowering scientists to see biology at unprecedented resolution and accelerate the development of high-impact therapies.

Integrated platforms for single-cell and spatial genomics, including Chromium for single-cell multiomics, Xenium for subcellular spatial imaging of RNA and protein, and Visium for spatial transcriptomics within tissue morphology.

Total raised: $460M

Main competitors include BD (Rhapsody) and Parse Biosciences in single-cell sequencing, and NanoString (GeoMx, CosMx), Akoya Biosciences, and Vizgen in spatial biology. 10X differentiates through its integrated single-cell + spatial ecosystem, scale, extensive IP portfolio, and strong publication record.